Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin infusion to prevent vasoplegic syndrome in losartan-treated CABG patients
PACTR201804003249274Completed
- Sponsor
- Ain Shams University Hospitals
- Start
- Nov 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Trial of terlipressin in Vasoplegia (2 arms), sponsored by Ain Shams University Hospitals. Primary endpoint: Incidence of vasoplegic syndrome. Started Nov 2017; status: completed.
02
Drugs
terlipressin
03
Conditions
Vasoplegia
Beyond the preview
Go deeper on PACTR201804003249274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201804003249274.